• Batf3-dependent DCs induced by RT promote anti-tumor immune responses by activating CD8 + T cells • DCs upregulate MHC-I after RT, promoting efficient tumor antigen presentation for better anti-tumor immune responses • RT enhances tumor antigen presenting capacity of infiltrating DC through type I IFN production. The gene discussed is BATF3; the disease is neoplasm.